Summary:
Efficacy and Safety of switching from sitabliptin to liraglutide I subjects with type 2 diabetes, not achieving adequate glycaemic control on sitagliptin and metformin.
Qualified Participants Must:
• Be at least 18 years of age
•
Have Type 2 DM
•
Have been using sitagliptin and metformin for at least 90 days
Qualified Participants May Receive:
Compensation for time and travel, eye exam, PE, EKG, Study visits, blood glucose testing supplies, study medication, lab testing, and diabetic teaching at no charge.